Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Gonzalez

Showing results (451-460 of 501) with videos related to

Pageof 51
Sort By:
Alternatives to Laboratory Animals : ATLA|September 27, 2024
Introducing the COST Action 'Improving the Quality of Biomedical Science with 3Rs Concepts' (IMPROVE)Maria Kitsara, Merima Smajlhodžić-Deljo, Lejla Gurbeta Pokvic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 17, 2025
Plasma N-terminal tau fragment is an amyloid-dependent biomarker in Alzheimer's diseaseGuoyu Lan, Laihong Zhang, Anqi Li, et al.
Neurology|August 19, 2025
Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer DiseaseSohyun Yim, Seongbeom Park, Kyoungyoon Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2017
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung CancerRamaswamy Govindan, Aleksandra Szczesna, Myung-Ju Ahn, et al.
Alzheimer'S Research & Therapy|January 15, 2026
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical useHeekyoung Kang, Yuna Gu, Jungah Lee, et al.
Nature Communications|February 1, 2026
Biomarker-integrated prognostic stagings for Alzheimer's DiseaseDaeun Shin, Sungjoo Lee, Jun Pyo Kim, et al.
Journal of Neurointerventional Surgery|March 12, 2024
Prolonged venous transit on perfusion imaging is associated with higher odds of mortality in successfully reperfused patients with large vessel occlusion strokeVivek S Yedavalli, Manisha Koneru, Meisam Hoseinyazdi, et al.
Molecular Psychiatry|April 1, 2025
Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer's diseaseGuoyu Lan, Anqi Li, Fernando Gonzalez-Ortiz, et al.
The Journal of Pediatrics|July 19, 2021
Physician-Scientist Training and Programming in Pediatric Residency Programs: A National SurveyAudrea M Burns, Daniel J Moore, Catherine S Forster, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2023
A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's diseaseFernando Gonzalez-Ortiz, Pamela C L Ferreira, Armand González-Escalante, et al.
Pageof 51

Showing results (451-460 of 501) with videos related to

Sort By:
Pageof 51
Alternatives to Laboratory Animals : ATLA|September 27, 2024
Introducing the COST Action 'Improving the Quality of Biomedical Science with 3Rs Concepts' (IMPROVE)Maria Kitsara, Merima Smajlhodžić-Deljo, Lejla Gurbeta Pokvic, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 17, 2025
Plasma N-terminal tau fragment is an amyloid-dependent biomarker in Alzheimer's diseaseGuoyu Lan, Laihong Zhang, Anqi Li, et al.
Neurology|August 19, 2025
Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer DiseaseSohyun Yim, Seongbeom Park, Kyoungyoon Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2017
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung CancerRamaswamy Govindan, Aleksandra Szczesna, Myung-Ju Ahn, et al.
Alzheimer'S Research & Therapy|January 15, 2026
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical useHeekyoung Kang, Yuna Gu, Jungah Lee, et al.
Nature Communications|February 1, 2026
Biomarker-integrated prognostic stagings for Alzheimer's DiseaseDaeun Shin, Sungjoo Lee, Jun Pyo Kim, et al.
Journal of Neurointerventional Surgery|March 12, 2024
Prolonged venous transit on perfusion imaging is associated with higher odds of mortality in successfully reperfused patients with large vessel occlusion strokeVivek S Yedavalli, Manisha Koneru, Meisam Hoseinyazdi, et al.
Molecular Psychiatry|April 1, 2025
Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer's diseaseGuoyu Lan, Anqi Li, Fernando Gonzalez-Ortiz, et al.
The Journal of Pediatrics|July 19, 2021
Physician-Scientist Training and Programming in Pediatric Residency Programs: A National SurveyAudrea M Burns, Daniel J Moore, Catherine S Forster, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2023
A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's diseaseFernando Gonzalez-Ortiz, Pamela C L Ferreira, Armand González-Escalante, et al.
Pageof 51